News

LabVantage Awarded US Army Contract for LIMS COVID-19 Vaccine Support

October 13, 2020

The company will supply its LIMS to the Walter Reed Army Institute of Research (WRAIR) to support vaccine production programs for COVID-19 at WRAIR’s pilot bioproduction facility.

Lachman Now Offers Remote Inspections

October 13, 2020

Virtual Touring allows companies to inspect and visit vendor and contract partner sites remotely during the COVID-19 pandemic.

J&J Pauses COVID-19 Vaccine Candidate Clinical Trials Due to Unexplained Illness

October 13, 2020

The unexplained illness in a study participant is being reviewed and evaluated by an independent data safety monitoring board and internal clinical and safety physicians.

HHS, DoD, AstraZeneca Enter into $486-Million Agreement for COVID-19 Investigational Product

October 12, 2020

The companies are entering into an agreement for the late-stage development and large-scale manufacturing of AZD7442, AstraZeneca’s investigational product for treatment and prevention of COVID-19.

Cambrex Completes Expansion of Edinburgh Solid Form Screening Facility

October 12, 2020

The expansion has doubled Cambrex’s footprint to 15,000 ft2, including an added 3500 ft2 of laboratory space.

Industry Backs Clear FDA Standards for COVID Vaccine Authorization

October 09, 2020

Bio/pharma industry leaders support FDA’s newly published EUA guidance for COVID-19 vaccine authorization.

Rentschler to Partner with BioNTech for COVID-19 Vaccine Manufacturing

October 09, 2020

Rentschler will handle the downstream processing to provide highly purified drug substance at its headquarters in Laupheim, Germany.

Fujifilm Cellular Dynamics and Axxam Team Up for Drug Discovery Platform

October 09, 2020

The partnership aims to provide a platform of hiPSC-based assays, drug discovery technologies, high-throughput screening, and high-content screening.

Continuity Pharma Receives DARPA Grant for Continuous Manufacturing

October 08, 2020

Purdue University’s Continuity Pharma received a $1.5-million grant from DARPA to develop continuous manufacturing technology for generic drug products.

Pharm-Olam Selected to Join BARDA’s Clinical Studies Network

October 08, 2020

Under the contract, Pharm-Olam will offer routine and response clinical services for the development of medical countermeasures.